Skip to main content

Distinguished Speaker Series | Audrone Lapinaite, PhD

-
Location
https://ucihealth.zoom.us/j/92801383742?pwd=vfI4WBKGwibdfbtyznYWvAbSg3CccO.1
Event Type

Add to Calendar: Outlook | Google | iCal

The Center for Translational Vision Research Distinguished Speaker Series, also known as "Friday Seminars" showcases innovative research across the world. The seminar series has now been expanded to include lectures by experts on topics ranging from Ophthalmology, Genetics, Biochemistry, Neurobiology, Imaging, Computational Sciences to Novel Ophthalmic Treatments.

All talks are hybrid. You can join us in person at

The Falling Leaves Foundation Building, Main Entrance Level

Conference Room (2nd Floor by signage)

847 Health Sciences Quad

You can also join us by zoom. Zoom link and information are on your right and in the calendar links above.

April 3, 2026 | Audrone Lapinaite, PhD

Advancing Precision Genome Editing for Therapeutic Applications

 

Learn More About the Distinguished Speaker Series

Featured


Audrone Lapinaite, PhD
Audrone Lapinaite, PhD
  • Audrone Lapinaite, PhD, Assistant Professor, Gavin Herbert Eye Institute, Brunson Center for Translational Vision Research, Departments of Ophthalmology and Visual Sciences, Biomedical Engineering, and Biological Chemistry University of California, Irvine

Audrone Lapinaite, Ph.D., is an Assistant Professor in the Department of Physiology & Biophysics at the University of California, Irvine. Trained as a structural biologist, Dr. Lapinaite’s research focuses on understanding the molecular architecture and regulation of protein complexes that govern essential cellular processes. Her laboratory uses cryo–electron microscopy and complementary biochemical approaches to visualize macromolecular assemblies at high resolution and uncover how their structure relates to function. By investigating how these complexes are assembled, regulated, and disrupted in disease states, her work aims to reveal fundamental mechanisms of cellular control and identify new molecular targets with therapeutic potential.